The firm increased its portfolio allocation in GSK by 13.25% over the last quarter. GSK Background Information (This description is provided by the company.) GSK is a science-led global healthcare ...

GlaxoSmithKline chief executive Emma Walmsley ... experience" – which may be an oblique reference to Walmsley's background in consumer health. According to the latter, shareholders "still ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other FTSE dividend stocks. Goldman Sachs Research predicts moderate growth for the UK economy in 2025 ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK is nearing a $1bn deal to buy a US biotech developing a treatment for rare gastrointestinal tumours ...